DNAPrint genomics, Inc. Announces Completion of Audit
SARASOTA, Fla., Sep 20, 2000 (BUSINESS WIRE) -- DNAPrint genomics, Inc., (Pink
Sheets:DNAP), a Sarasota, Fla. based genomics company, announced today that the
CPA firm of Howard Wolmerdorf, C.P.A., P.A., has completed the audit of DNAPrint
genomics, Inc., f/k/a Catalyst Communications, Inc., through the year ending
December 31, 1999.
The Company will now move immediately to establish itself as a registrant with
the SEC and to be listed on the Nasdaq OTC Bulletin Board.
Chief Scientific Officer, Dr. Tony Frudakis stated, "The completion of our
audits is another important milestone in our quest to become a reporting company
with the Securities and Exchange Commission. DNAPrint plans to work
expeditiously to complete the remaining requirements for listing on the
OTC-Bulletin Board."
About DNAPrint genomics
DNAPrint genomics, Inc. provides practitioners of genomic research and
personalized medicine with a comprehensive system for complex trait dissection
and patient classification. DNAPrint genomics, Inc. was founded by a group of
scientists with research and commercial experience in high-level mathematical
modeling, programming and molecular genetics. For more information about the
company, please visit www.dnaprint.com.
Except for factual statements made herein, the information contained in this
press release consists of forward-looking statements that involve risks and
uncertainties. The Company's actual results could differ materially from those
contained in such statements. Factors that could cause or contribute to such
differences include unexpected shortages of critical components, rescheduling or
cancellation of customer orders, the timing and market acceptance of new product
introductions by the Company and its competitors, and general competition and
price pressures in the marketplace.
CONTACT: DNAPrint genomics, Inc., Sarasota
For scientific inquiries please contact:
Dr. Tony Frudakis, 941/351-4543
or
All other inquiries please contact:
Richard Craig Hall, 941/341-0136 |
